Ad hoc announcement pursuant to Art. 53 LR Broad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for CDK4/6 ...
CNET's weekly recap highlights 5-ish things you should know about AI. Subscribe now to also receive "The Art of the Prompt," our complete guide to getting effective answers from AI tools.